P02976 (SPA_STAA8) Staphylococcus aureus (strain NCTC 8325 / PS 47)
Immunoglobulin G-binding protein A UniProtKBInterProSTRINGInteractive Modelling
516 aa; Sequence (Fasta)
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Middle Region of Apolipoprotein B 100 bound to Low Density Lipoprotein Receptor |
Heteromer P01130; P04114; P0AEX9; P19909; | 100 | 5×NAG; 7×CA; | |||
| Nanobody 4 bound to Apolipoprotein B 100 |
Heteromer P01130; P04114; P0AEX9; | 67.35 | 3×NAG; 3×CA; | |||
| Apolipoprotein B 100 bound to LDL receptor and legobody |
Heteromer P01130; P04114; P06654; P0AEX9; | 67.35 | 1×NAG; 4×NAG; 7×CA; | |||
| Coevolved affibody-Z domain pair LL1.c4 |
Heteromer | 91.38 | 1×GOL; | |||
| An affibody in complex with a target protein: structure and coupled folding |
Heteromer | 96.55 | ||||
| Coevolved affibody-Z domain pair LL1.c6 |
Heteromer | 92.98 | 1×MLI; | |||
| Coevolved affibody-Z domain pair LL1.c1 |
Heteromer | 91.23 | 1×SO4; 2×MLI; | |||
| Coevolved affibody-Z domain pair LL2.c22 |
Heteromer | 91.07 | 1×GOL; | |||
| Coevolved affibody-Z domain pair LL2.c3 |
Heteromer | 92.86 | 1×GOL; 1×SO4; | |||
| Coevolved affibody-Z domain pair LL1.c5 |
Heteromer | 92.86 | ||||
| Coevolved affibody-Z domain pair LL1.c2 |
Heteromer | 92.86 | ||||
| Application of anti-helix antibodies in protein structure determination (8496-3LRH) |
Heteromer | 82.14 | ||||
| Coevolved affibody-Z domain pair LL2.c1 |
Heteromer | 92.73 | 1×GOL; | |||
| IgG Fc bound to 3 helix of the B-domain from Protein A |
Heteromer P01857; | 98.11 | 1×NAG; 1×NAG; | |||
| Coevolved affibody-Z domain pair LL2.c7 |
Heteromer | 92.45 | 1×MLI; | |||
| Coevolved affibody-Z domain pair LL2.c17 |
Heteromer | 94.23 | ||||
| Application of anti-helix antibodies in protein structure determination (8188cys-3LRHcys) |
Heteromer | 96.15 | ||||
| CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-PEG3-MEDITOPE |
Heteromer Q51918; | 100 | 1×MRY; | |||
| STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT |
Heteromer Q51918; | 100 | 1×MRY; | |||
| Application of anti-helix antibodies in protein structure determination (8189-3LRH) |
Heteromer | 96.08 | ||||
| MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK |
Heteromer Q51918; | 100 | 1×MRY; | |||
| Trastuzumab Fab v3 |
Heteromer P01834; Q51918; S6B291; | 100 | ||||
| CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO-MEDITOPE |
Heteromer Q51918; | 100 | 1×MRY; | |||
| Trastuzumab Fab v3 with 5-diphenyl meditope variant |
Heteromer P01834; Q51918; Q6GMX6; | 100 | ||||
| Application of anti-helix antibodies in protein structure determination (8188-3LRH) |
Heteromer | 96.08 | ||||
| Trastuzumab Fab v3 in complex with CQFDLSTRRLKC |
Heteromer P01834; Q51918; S6B291; | 100 | ||||
| Trastuzumab Fab v3 in complex with 5-phenyl meditope variant |
Heteromer P01834; Q51918; Q6GMX6; | 100 | ||||
| Structure of S. aureus protein A bound to a human IgM Fab |
Heteromer | 100 | ||||
| YZwIdeal x16 a scaffold for cryo-EM of small proteins of interest crystallizing in space group 19 (… |
Heteromer P42588; | 100 | 4×PLP; | |||
| Application of anti-helix antibodies in protein structure determination (9014-1P4B) |
Heteromer | 91.84 | ||||
| Application of anti-helix antibodies in protein structure determination (8420-3MNZ) |
Heteromer | 95.45 | ||||
| helix shuffled variant of domain B pf protein A | monomer | 77.78 | ||||
| NMR solution structure of staphylococcal protein A, C domain | monomer | 100 | ||||
6 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4npf.2.A | monomer | 0.72 | 74.34 | |||
| 4npf.2.A | monomer | 0.72 | 93.97 | |||
| 4npf.2.A | monomer | 0.68 | 93.10 | |||
| 5h7b.1.A | monomer | 0.65 | 83.26 | |||
| 9coo.1.B | monomer | 0.59 | 71.96 | |||
| 9coo.1.B | monomer | 0.59 | 75.70 | |||